a Department of Radiation Oncology , University Medical Center Utrecht , Utrecht , The Netherlands.
b Department of Surgery , Medical Center Leeuwarden , Leeuwarden , The Netherlands.
Acta Oncol. 2019 Apr;58(4):407-416. doi: 10.1080/0284186X.2018.1551622. Epub 2019 Jan 18.
Neoadjuvant chemoradiation with delayed surgery (CRT-DS) and short-course radiotherapy with immediate surgery (SCRT-IS) are two commonly used treatment strategies for rectal cancer. However, the optimal treatment strategy for patients with intermediate-risk rectal cancer remains a discussion. This study compares quality of life (QOL) between SCRT-IS and CRT-DS from diagnosis until 24 months after treatment.
In a prospective colorectal cancer cohort, rectal cancer patients with clinical stage T2-3N0-2M0 undergoing SCRT-IS or CRT-DS between 2013 and 2017 were identified. QOL was assessed using EORTC-C30 and EORTC-CR29 questionnaires before the start of neoadjuvant treatment (baseline) and at 3, 6, 12, 18 and 24 months after. Patients were 1:1 matched using propensity sore matching. Between- and within-group differences in QOL domains were analyzed with linear mixed-effects models. Symptoms and sexual interest at 12 and 24 months were compared using logistic regression models.
156 of 225 patients (69%) remained after matching. The CRT-DS group reported poorer emotional functioning at 3, 6, 12, 18 and 24 months (mean difference with SCRT-IS: -9.4, -12.1, -7.3, -8.0 and -7.9 respectively), and poorer global health, physical-, role-, social- and cognitive functioning at 6 months (mean difference with SCRT-IS: -9.1, -9.8, -14.0, -9.2 and -12.6, respectively). Besides emotional functioning, all QOL domains were comparable at 12, 18 and 24 months. Within-group changes showed a significant improvement of emotional functioning after baseline in the SCRT-IS group, whereas only a minor improvement was observed in the CRT-DS group. Symptoms and sexual interest in male patients at 12 and 24 months were comparable between the groups.
In rectal cancer patients, CRT-DS may induce a stronger decline in short-term QOL than SCRT-IS. From 12 months onwards, QOL domains, symptoms and sexual interest in male patients were comparable between the groups. However, emotional functioning remained higher after SCRT-IS than after CRT-DS.
新辅助放化疗后延迟手术(CRT-DS)和短程放疗后即刻手术(SCRT-IS)是直肠癌的两种常用治疗策略。然而,对于中危直肠癌患者,最佳的治疗策略仍存在争议。本研究比较了 SCRT-IS 和 CRT-DS 从诊断到治疗后 24 个月之间的生活质量(QOL)。
在一项前瞻性结直肠癌队列研究中,确定了 2013 年至 2017 年间接受 SCRT-IS 或 CRT-DS 的临床 T2-3N0-2M0 期直肠癌患者。在新辅助治疗开始前(基线)以及治疗后 3、6、12、18 和 24 个月使用 EORTC-C30 和 EORTC-CR29 问卷评估 QOL。采用倾向评分匹配进行 1:1 匹配。使用线性混合效应模型分析 QOL 域的组间和组内差异。使用逻辑回归模型比较 12 个月和 24 个月时的症状和性兴趣。
匹配后 225 例患者中有 156 例(69%)保留。CRT-DS 组在 3、6、12、18 和 24 个月时报告的情绪功能较差(与 SCRT-IS 相比的平均差异:分别为-9.4、-12.1、-7.3、-8.0 和-7.9),而在 6 个月时报告的总体健康、身体、角色、社会和认知功能较差(与 SCRT-IS 相比的平均差异:分别为-9.1、-9.8、-14.0、-9.2 和-12.6)。除情绪功能外,所有 QOL 域在 12、18 和 24 个月时均具有可比性。组内变化显示 SCRT-IS 组在基线后情绪功能显著改善,而 CRT-DS 组仅观察到轻微改善。12 个月和 24 个月时,两组男性患者的症状和性兴趣相当。
在直肠癌患者中,CRT-DS 可能比 SCRT-IS 导致更短期的 QOL 下降。从 12 个月开始,两组患者的 QOL 域、症状和男性患者的性兴趣相当。然而,SCRT-IS 后情绪功能仍高于 CRT-DS。